Repercussions of the patent application disclosure process for medical device companies intending to profit from their inventions has long been under-discussed. Industries across the board have the shared experience of navigating two agency approvals, one from the U.S. Food and Drug Administration (FDA), and another from the U.S. Patent and Trade Office. Recently, a fascinating examination of this process was provided by Knobbe Martens.
The FDA oversees the approval of “indications for use” information for a given product from a medical device company. This information is crucial for being able to legally sell their products within the U.S. Conversely, securing U.S. patent protection enables these companies to earn profits from their respective inventions. Both these approval processes require convincing government agencies of the respective claims’ validity.
Whilst it’s common knowledge to professionals within the legal jurisdiction of the healthcare industry, the correlation and potential implications between the statements made to the FDA and those mentioned in patent applications are nuanced.
Medical device companies need to maintain equilibrium ensuring that the assertions made during the approval process of patent applications and FDA requests align. An unlevelled ground could raise issues challenging the credibility of a patent if it’s put through litigation.
Strategic navigation through these legal hoops is crucial for these companies. It’s not only about securing their right to profit from their inventions but also about maintaining a solid foothold in the largely competitive pharmaceutical and medical device industry. By focusing on an effective persuasive strategy – one that appeals to two distinct federal entities – companies can ensure their products are marketable and profitable simultaneously.
Legal practitioners in this field need to provide a comprehensive approach that enables their clients to straddle both agencies smoothly. The advent of a streamlined, legitimate approach is paramount to the overall trajectory of device companies aiming for success in this industry.